Cargando...
Enhanced Control of Oncolytic Measles Virus Using MicroRNA Target Sites
Measles viruses derived from the live-attenuated Edmonton-B vaccine lineage are currently investigated as novel anti-cancer therapeutics. In this context, tumor specificity and oncolytic potency are key determinants of the therapeutic index. Here, we describe a systematic and comprehensive analysis...
Guardado en:
| Publicado en: | Mol Ther Oncolytics |
|---|---|
| Autores principales: | , , , , , , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
American Society of Gene & Cell Therapy
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6026446/ https://ncbi.nlm.nih.gov/pubmed/29988512 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omto.2018.04.002 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|